- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06353529
Sphenopalatine Ganglion Block for Postop Pain Management (SPGB)
Effect of Sphenopalatine Ganglion Block With Bupivacaine on Postoperative Pain in Patients Undergoing Endoscopic Pituitary Adenoma Resection
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
To further improve the quality of the early postoperative course, the investigators propose the use of the sphenopalatine ganglion (SPG) block (SPGB) for pain management in the context of an enhanced recovery after surgery (ERAS) protocol for minimally invasive (MIS) endoscopic transsphenoidal pituitary surgery. The SPG is the main sensory innervation to the nasal mucosa, and several studies have shown the analgesic efficacy of SPGB following sinus surgery and showed positive results for endoscopic sinus surgery. However, there is limited research on the use of SPGB in the context of pituitary surgery.
In this randomized placebo-controlled trial, the investigators aim to assess the benefit of SPGB with bupivacaine in addition to multimodal general anesthesia on pain management, after MIS pituitary surgery. The results of the trial will provide valuable insights into the potential benefits of SPGB and its optimal use for pituitary surgery.
Study Type
Enrollment (Estimated)
Phase
- Phase 4
Contacts and Locations
Study Contact
- Name: Ms. Jessy Moore, MSc
- Phone Number: 289-686-8827
- Email: moorej@hhsc.ca
Study Contact Backup
- Name: Dr. Kesava Reddy, MD
- Phone Number: 905-521-2100
- Email: reddy@hhsc.ca
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada, L8L 2X2
- Hamilton General Hospital
-
Contact:
- Ms. Jessy Moore, MSc
- Phone Number: 289-686-8827
- Email: moorej@hhsc.ca
-
Contact:
- Dr. Kesava Reddy, MD
- Phone Number: 905-521-2100
- Email: reddy@hhsc.ca
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- adult patients (18 yrs or older)
- undergoing endonasal pituitary adenoma resection
Exclusion Criteria:
- Patients with pre-existing chronic pain conditions requiring antidepressants (serotonin reuptake inhibitors), benzodiazepines, gabapentin, or opioid drugs
- contraindications to the performance of SPGB such as known allergy to used medications
- chronic alcohol abuse
- uncontrolled systemic arterial hypertension
- severe kidney or liver diseases
- cardiomyopathies or sustained cardiac arrhythmias (permanent paroxystic atrial fibrillation or other sustained supraventricular rhythmic anomalies)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Bupivacaine injection
This group will receive bilateral injection of 0.5% bupivacaine with 1:200,000 epinephrine using a 20G needle and comprising 2mL of fluid on each side (4mL total) into the sphenopalatine ganglion.
|
2mL injection bilateral (4mL total) of 0.5% bupivacaine with 1:200,000 epinephrine solution, 20G needle, sterile, sphenopalatine ganglion; nerve block
|
Placebo Comparator: Placebo Control
This group will receive bilateral injection of 0.9% saline solution using a 20G needle and comprising 2mL of fluid on each side (4mL total) into the sphenopalatine ganglion.
|
2mL injection bilateral (4mL total) 0.9% saline solution, 20G needle, sterile, sphenopalatine ganglion; nerve block
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Post-operative pain score
Time Frame: through study completion, approximately 1 year
|
Pain score, measured by visual analog scale (scale of 0-10) at 6, 12 and 24 hours post-op
|
through study completion, approximately 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Post-operative bleeding
Time Frame: through study completion, approximately 1 year
|
amount of post-op bleeding (mL) in first 24 hours
|
through study completion, approximately 1 year
|
Post-operative complications
Time Frame: through study completion, approximately 1 year
|
record presence of post-op nausea/vomiting, headache, sore throat, difficulty swallowing in first 24 hours
|
through study completion, approximately 1 year
|
Analgesic requirement
Time Frame: through study completion, approximately 1 year
|
List and dose of analgesics administered to patient in first 24 hours or time of discharge, whichever comes first
|
through study completion, approximately 1 year
|
Length of stay
Time Frame: through study completion, approximately 1 year
|
Length of hospital stay in hours
|
through study completion, approximately 1 year
|
Collaborators and Investigators
Investigators
- Principal Investigator: Dr. Kesava Reddy, MD, Hamilton Health Sciences Corporatin
Publications and helpful links
General Publications
- Kesimci E, Ozturk L, Bercin S, Kiris M, Eldem A, Kanbak O. Role of sphenopalatine ganglion block for postoperative analgesia after functional endoscopic sinus surgery. Eur Arch Otorhinolaryngol. 2012 Jan;269(1):165-9. doi: 10.1007/s00405-011-1702-z. Epub 2011 Jul 8.
- Morisse M, Rysman B, Szymanski C, Fackeure R, Mouawad F, Mortuaire G. A randomized placebo-controlled trial assessing sphenopalatine ganglion block in endoscopic sinus surgery. Int Forum Allergy Rhinol. 2021 Sep;11(9):1384-1386. doi: 10.1002/alr.22804. Epub 2021 May 19. No abstract available.
- Rezaeian A, Hashemi SM, Dokhanchi ZS. Effect of Sphenopalatine Ganglion Block With Bupivacaine on Postoperative Pain in Patients Undergoing Endoscopic Sinus Surgery. Allergy Rhinol (Providence). 2019 Jan 23;10:2152656718821282. doi: 10.1177/2152656718821282. eCollection 2019 Jan-Dec.
- Kim DH, Kang H, Hwang SH. The Effect of Sphenopalatine Block on the Postoperative Pain of Endoscopic Sinus Surgery: A Meta-analysis. Otolaryngol Head Neck Surg. 2019 Feb;160(2):223-231. doi: 10.1177/0194599818805673. Epub 2018 Oct 9.
- Wang P. The efficacy of sphenopalatine ganglion block for pain management after endoscopic sinus surgery: a meta-analysis of randomized controlled studies. Eur Arch Otorhinolaryngol. 2021 Aug;278(8):2681-2687. doi: 10.1007/s00405-020-06484-9. Epub 2021 Jan 3.
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Neoplasms
- Postoperative Complications
- Pain
- Neurologic Manifestations
- Endocrine System Diseases
- Cysts
- Connective Tissue Diseases
- Hypothalamic Diseases
- Mucinoses
- Pain, Postoperative
- Pituitary Diseases
- Ganglion Cysts
- Physiological Effects of Drugs
- Adrenergic Agents
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Autonomic Agents
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Adrenergic alpha-Agonists
- Adrenergic Agonists
- Anesthetics, Local
- Bronchodilator Agents
- Anti-Asthmatic Agents
- Respiratory System Agents
- Adrenergic beta-Agonists
- Sympathomimetics
- Vasoconstrictor Agents
- Mydriatics
- Bupivacaine
- Epinephrine
Other Study ID Numbers
- 17065
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Patient data will be de-identified and the data will be analyzed as a whole before becoming available to other researchers.
De-identified IPD may be shared with other researchers if necessary based on occurrence of adverse events occurrence, circumstantial findings, etc.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain, Postoperative
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
-
Ankara City Hospital BilkentRecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | SternotomyTurkey
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Aydin Adnan Menderes UniversityCompleted
-
Aydin Adnan Menderes UniversityCompletedAcute Postoperative Pain | Chronic Postoperative PainTurkey
-
Maimonides Medical CenterCompletedPOSTOPERATIVE PAINUnited States
-
University Hospital, AntwerpUnknown
-
VA Office of Research and DevelopmentRecruitingTotal Knee Arthroplasty (Postoperative Pain) | Total Hip Arthroplasty (Postoperative Pain)United States
-
VA Office of Research and DevelopmentCompletedTotal Knee Arthroplasty (Postoperative Pain) | Total Hip Arthroplasty(Postoperative Pain)United States
Clinical Trials on Bupivacaine-Epinephrine 0.5%-1:200,000 Injectable Solution
-
University of AarhusTerminated
-
Weill Medical College of Cornell UniversityCompleted
-
Lalonde, Donald H., M.D.Completed
-
Bozyaka Training and Research HospitalNot yet recruitingPain, Postoperative | Brachial Plexus Block | Anesthesia and Analgesia | Nerve Block | Anesthesia Conduction | Upper Extremity SurgeryTurkey
-
Scott and White Hospital & ClinicCompleted
-
CES UniversityCompletedTeeth, ImpactedColombia
-
Sunnybrook Health Sciences CentreCompletedBrachial Plexus Block | Anesthetics, LocalCanada
-
Ryan Mountjoy, MDMaineHealthRecruitingPain, Postoperative | AmputationUnited States
-
Jessyka LighthallEnrolling by invitation
-
John O'TooleRecruitingSynovial Cyst | Lumbar Disc Herniation | Degenerative Disc Disease | Lumbar Spinal Stenosis | Lumbar Spondylolisthesis | Lumbar Radiculopathy | Lumbar Spondylosis | Degenerative Spondylolisthesis | Lumbar Spine Instability | Degenerative Intervertebral DiscsUnited States